Google DeepMind launched AlphaGenome, an AI tool that identifies genetic mutations driving disease.
AlphaGenome analyses up to one million DNA letters at once.
The system predicts how mutations disrupt gene regulation across different cells and tissues.
Researchers trained the model on public human and mouse genetics databases.
Scientists say it could speed discovery of disease mechanisms and new treatments.
Experts believe AlphaGenome may guide future gene and cancer therapies.
Google DeepMind Unveils AlphaGenome to Decode Genetic Causes of Disease
OMN AI
This article was created with the assistance of OMN AI, the AI-powered editorial platform developed by OMN Group. Every article is reviewed, fact-checked, and approved by a human journalist before publication to ensure accuracy and editorial quality. Learn more at https://omngroup.com
